Mar 6, 2026 07:30AM
Mar 5, 2026 06:31AM
Feb 26, 2026 07:30AM
Feb 25, 2026 07:30AM
Feb 6, 2026 07:30AM
Jan 12, 2026 04:07AM
Jan 11, 2026 05:00PM Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
Jan 5, 2026 07:30AM
Dec 8, 2025 10:30AM
Dec 8, 2025 10:30AM
Dec 3, 2025 08:32AM
Dec 2, 2025 08:02AM
Dec 2, 2025 08:02AM
Nov 25, 2025 05:19PM KOMZIFTI added to NCCN guidelines for relapsed AML treatment
Nov 25, 2025 05:16PM
Nov 20, 2025 04:02AM
Nov 13, 2025 10:51AM
Nov 13, 2025 10:51AM
Nov 13, 2025 10:15AM
Nov 4, 2025 06:31AM
Oct 1, 2025 07:01AM Kura Oncology and Kyowa Kirin begin trial combining cancer drugs for AML
Oct 1, 2025 07:01AM
Sep 30, 2025 06:52AM
Sep 29, 2025 04:01PM
Sep 29, 2025 04:01PM
Sep 25, 2025 05:19PM
Sep 25, 2025 05:18PM
Sep 4, 2025 05:44AM Guggenheim Starts Kura Oncology (KURA) at Neutral
Aug 7, 2025 04:05PM
Aug 4, 2025 07:30AM
Jul 31, 2025 07:30AM
Jul 3, 2025 07:30AM
Jun 12, 2025 07:31AM
Jun 12, 2025 07:30AM
Jun 6, 2025 07:30AM Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 4, 2025 04:29AM
Jun 3, 2025 07:39AM
Jun 2, 2025 06:01PM
Jun 2, 2025 06:00PM
Jun 2, 2025 06:53AM
Jun 1, 2025 07:14PM
Jun 1, 2025 07:00PM Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML
May 22, 2025 05:36PM
May 22, 2025 05:30PM
May 20, 2025 07:30AM
May 14, 2025 10:00AM
May 6, 2025 07:30AM
May 2, 2025 07:30AM
May 1, 2025 04:05PM Kura Oncology Reports First Quarter 2025 Financial Results
Apr 28, 2025 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All